logo

Latest Financial Updates

Read latest financial news update from our blog

Pre-Orders Add to Your Bottom Line—How Do They Work? (2023)
Pre-Orders Add to Your Bottom Line—How Do They Work? (2023)

"The waiting is the hardest part." It isn’t just a song lyric—when it comes to ecommerce,...

Admin | Finance | 2 months ago

Katherine Heigl’s New Role As Entrepreneur (2024)
Katherine Heigl’s New Role As Entrepreneur (2024)

Katherine Heigl has had many memorable roles, from her Emmy Award–winning portrayal of Izz...

Admin | Finance | 2 months ago

Following Asian Countries’ Leads, Climate Action Opportunity for Developing Nations
Following Asian Countries’ Leads, Climate Action Opportunity for Developing Nations

Last year, the second largest rain forest nation saw close to zero deforestation, an enorm...

Admin | Finance | 2 months ago

Lok Sabha Polls 2024: Better MSME Credit Access, Support For Green Switch On Industry Wishlist
Lok Sabha Polls 2024: Better MSME Credit Access, Support For Green Switch On Industry Wishlist

Ahead of the Lok Sabha elections of 2024, expanding funding options for both capital expen...

Admin | Finance | 2 months ago

Meta unveils new AI chip
Meta unveils new AI chip

Meta Platforms on Wednesday unveiled details about the next generation of the company’s in...

Admin | Finance | 2 months ago

Inboxes: Create long lasting disposable emails in Chrome
Inboxes: Create long lasting disposable emails in Chrome

Inboxes Create long lasting disposable emails in Chrome Inboxes Create long lasting dispo...

Admin | Finance | 2 months ago

Asia markets mostly negative after U.S. inflation hotter than expected, China CPI slows
Asia markets mostly negative after U.S. inflation hotter than expected, China CPI slows

Japan (NKY:IND) -0.35%. China (SHCOMP) +0.23%. China's consumer prices edged up 0.1% Y/Y...

Admin | Finance | 2 months ago

Sarepta Therapeutics: Growth Trajectory Alters Trading Strategy (NASDAQ:SRPT)
Sarepta Therapeutics: Growth Trajectory Alters Trading Strategy (NASDAQ:SRPT)

champja In my last Sarepta Therapeutics (NASDAQ:SRPT) article, I discussed Sarepta's Q3 p...

Admin | Finance | 2 months ago

Join Our Newsletter

join our newsletter to receive update from us